Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics

There are over 15 disease-modifying drugs that have been approved over the last 20 years for the treatment of relapsing–remitting multiple sclerosis (MS), but there are limited treatment options available for progressive MS. The development of new drugs for the treatment of progressive MS remains ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamma, Emily, Lasisi, Wendy, Libner, Cole, Ng, Huah Shin, Plemel, Jason R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830034/
https://www.ncbi.nlm.nih.gov/pubmed/35144628
http://dx.doi.org/10.1186/s12974-022-02408-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830034/
https://www.ncbi.nlm.nih.gov/pubmed/35144628
http://dx.doi.org/10.1186/s12974-022-02408-y

Ejemplares similares